Cardioprotective and anti-inflammatory effects of treatment with adenocaine/mg2+ in a porcine model of endotoxemia

Granfeldt, Asger, Letson, Hayley L,, Dobson, Geoffrey P., Shi, WeiWei, Vinten-Johansen, Jakob, and Tønnesen, Else (2013) Cardioprotective and anti-inflammatory effects of treatment with adenocaine/mg2+ in a porcine model of endotoxemia. Circulation, 128 (122). A195.

PDF (Abstract Only) - Published Version
Download (38kB) | Preview
View at Publisher Website:


Introduction: The combination of adenosine + lidocaine (adenocaine) and Mg2+ (ALM) has demonstrated cardioprotective properties in models of cardiac arrest and hemorrhagic shock, and anti-neutrophil effects in vitro. This study evaluates whether ALM also demonstrates cardioprotective and anti-inflammatory properties in an endotoxemic porcine model.

Methods: Pigs (37-42kg) received lipopolysaccharide (LPS) at 1 µg/kg/h for 5 hours, and were randomized to: LPS (control) (n=8) or LPS + ALM (n=8). Pigs received a bolus of ALM at start of LPS infusion followed by 4 hours of infusion. Cardiac function was evaluated using pressure-volume loops, and inflammation was assessed by plasma TNF-α and leukocyte superoxide generation.

Results: Infusion of ALM maintained mean arterial pressure (MAP) at a lower level during the 4 hour infusion period (ALM: 47 ± 1.6 mmHg vs. control: 80 ± 2.9 mmHg, p<0.0001). After discontinuation of ALM, MAP immediately returned to and was maintained at baseline group values (ALM: 89 ± 5 mmHg vs. control: 86 ± 3 mmHg).

The slope of the end-systolic pressure-volume relationship (ESPVR) was unchanged during the experiment in both groups. However, a rightward shift of the volume axis intercept (V0) in the control group indicated decreased contractility; this shift was not observed in the ALM group (control: -0.1 ± 12 ml vs. ALM: -32.5 ± 7.6 ml, p= 0.04). Preload recruitable stroke work (PRSW), an index of overall cardiac performance, decreased in the control group (baseline: 71 ± 4: end: 37 ± 4 mmHg · ml / ml), but was preserved in the ALM group (baseline: 72 ± 5; end: 62 ± 4 mmHg · ml / ml, p<0.001 between groups). Diastolic function evaluated by dP/dtmin (ALM 2221 ± 170 vs. 1793 ± 89 mmHg/sec; p=0.04) and Tau (ALM 36 ± 1.2 vs. 44 ± 2.2 msec; p=0.007) was also significantly improved in the ALM group. Peak TNF-α levels were lower in the ALM group (ALM 7653 ± 1092 vs. 11989 ±1057 pg/ml; p=0.01). While neutrophil superoxide anion release increased by 19 ± 27 % in the control group, it decreased by 74 ± 8% in the ALM group (p=0.0006).

Conclusions: In this porcine model of endotoxemia, ALM improved cardiac function and reduced the inflammatory response to LPS, thereby extending the beneficial effects of ALM as reported for cardiac surgery, hemorrhagic shock and cardiac arrest.

Item ID: 32312
Item Type: Article (Abstract)
ISSN: 1524-4539
Keywords: cardioprotection; inflammation; cardioprotective drugs; oxygen uptake
Additional Information:

Abstracts From the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium.

Date Deposited: 06 May 2014 04:35
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110299 Cardiovascular Medicine and Haematology not elsewhere classified @ 100%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920109 Infectious Diseases @ 50%
92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920199 Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified @ 50%
Downloads: Total: 73
Last 12 Months: 4
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page